Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Nobuaki Dobashi"'
Autor:
Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, Yoshihiro Hatta, Yoshiko Atsuta, Noriko Doki, Shingo Kurahashi, Yasunori Ueda, Nobuaki Dobashi, Tomoya Maeda, Yasuhiro Taniguchi, Masatsugu Tanaka, Shinichi Kako, Tatsuo Ichinohe, Takahiro Fukuda, Shigeki Ohtake, Yuichi Ishikawa, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki, on behalf of Japan Adult Leukemia Study Group
Publikováno v:
HemaSphere, Vol 7, Iss 6, p e899 (2023)
Externí odkaz:
https://doaj.org/article/d7e5a0987ca542338d175708144ea6e9
Autor:
Kazuhito Suzuki, Shingo Yano, Kaichi Nishiwaki, Koji Sano, Takaki Shimada, Yuichi Yahagi, Yoji Ogasawara, Katsuki Sugiyama, Shinobu Takahara, Takeshi Saito, Kinuyo Kasama, Jiro Minami, Hiroki Yokoyama, Yutaro Kamiyama, Atsushi Katsube, Hidekazu Masuoka, Mitsuji Katori, Tomohito Machishima, Aya Ouchi, Nobuaki Dobashi, Ken Kaito, Noriko Usui, Keisuke Aiba
Publikováno v:
Cancer Medicine, Vol 5, Iss 11, Pp 3051-3058 (2016)
Abstract The clinical features and prognostic significance of myeloma cells containing granules remain unclear. The purpose of this retrospective study was to investigate the clinical significance of granule‐containing myeloma cells in patients wit
Externí odkaz:
https://doaj.org/article/2620492b797f4764b73082a649898233
Autor:
Akihiro Takeshita, Norio Asou, Yoshiko Atsuta, Hiroaki Furumaki, Toru Sakura, Yasunori Ueda, Masashi Sawa, Nobuaki Dobashi, Yasuhiro Taniguchi, Rikio Suzuki, Masaru Nakagawa, Shigehisa Tamaki, Maki Hagihara, Katsumichi Fujimaki, Hitoshi Minamiguchi, Hiroyuki Fujita, Masamitsu Yanada, Yoshinobu Maeda, Noriko Usui, Yukio Kobayashi, Hitoshi Kiyoi, Shigeki Ohtake, Itaru Matsumura, Tomoki Naoe, Yasushi Miyazaki, the Japan Adult Leukemia Study Group
Publikováno v:
Cancers, Vol 12, Iss 6, p 1444 (2020)
Background: After long-term analysis of the JALSG-APL204 study we recently reported that maintenance therapy with tamibarotene was more effective than all-trans retinoic acid (ATRA) by reducing relapse in APL patients. Here, the clinical significance
Externí odkaz:
https://doaj.org/article/aebcdb6e50ea4cdbbbb66af997b35a70
Autor:
Masaharu Kawashima, Tadahiro Gunji, Rie Ohba, Atsushi Katsube, Kurumi Tsukamoto, Kei Hirano, Yuko Shiota, Noriko Usui, Kenichiro Ishii, Nobuaki Dobashi, Shingo Yano
Publikováno v:
Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi; 2024, Vol. 70 Issue 1, p27-32, 6p
Autor:
Noboru Asada, Jun Ando, Satoru Takada, Chikashi Yoshida, Kensuke Usuki, Atsushi Shinagawa, Kenichi Ishizawa, Toshihiro Miyamoto, Hiroatsu Iida, Nobuaki Dobashi, Sumiko Okubo, Hideyuki Honda, Tomomi Soshin, Yasuko Nishimura, Atsuko Tsutsui, Harumi Mukai, Kazuhito Yamamoto
Publikováno v:
Japanese Journal of Clinical Oncology.
Background In a Phase 3 international clinical trial (VIALE-C), venetoclax plus low-dose cytarabine improved the response rate and overall survival versus placebo plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia who we
Supplementary Table 1 from Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::426312b950ecea38dad4337d551c6428
https://doi.org/10.1158/0008-5472.22363482
https://doi.org/10.1158/0008-5472.22363482
Supplementary Table 2 from Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46208242bb674b056fbd0462b2e6934b
https://doi.org/10.1158/0008-5472.22363479.v1
https://doi.org/10.1158/0008-5472.22363479.v1
The mechanisms for “gain-of-function” phenotypes produced by mutant p53s such as enhanced proliferation, resistance to transforming growth factor-β–mediated growth suppression, and increased tumorigenesis are not known. One theory is that thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ea17ea0c5c4a0737d536b074e3c33b
https://doi.org/10.1158/0008-5472.c.6493731.v1
https://doi.org/10.1158/0008-5472.c.6493731.v1
Autor:
Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, Yoshihiro Hatta, Noriko Doki, Shingo Kurahashi, Yasunori Ueda, Nobuaki Dobashi, Tomoya Maeda, Yasuhiro Taniguchi, Masatsugu Tanaka, Shinichi Kako, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Shigeki Ohtake, Yuichi Ishikawa, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki
Publikováno v:
Blood. 140:6030-6032
Autor:
Fumihiko Hayakawa, Tomoko Hata, Yasushi Miyazaki, Shigeki Ohtake, Mitsuhiro Matsuda, Masahiro Onoda, Isamu Sugiura, Yukiyasu Ozawa, Maki Hagihara, Yukio Kobayashi, Tomoki Naoe, Toru Sakura, Noriko Doki, Hiroyuki Fujita, Hisayuki Yokoyama, Yoshihiro Hatta, Ryuko Cho, Yuichi Ishikawa, Nobuhiro Hiramoto, Masatsugu Tanaka, Toshiro Ito, Nobuaki Dobashi, Shinichi Kako, Tsuyoshi Kamae, Yasuhiro Taniguchi, Masaaki Tsuji, Shin Fujisawa, Yasunori Ueda, Yoshiko Atsuta, Satoshi Nishiwaki, Daiki Hirano, Youko Suehiro
Publikováno v:
Blood Advances
Key Points Dasatinib-based 2-step induction resulted in a 100% CR rate with minimal toxicities and 53% MRD negativity.This protocol treatment increased the number of HSCTs in CR1, thereby improving 3-year EFS.
Visual Abstract
The standard t
Visual Abstract
The standard t